CRM:NYSESalesforce, Inc. Analysis
Data as of 2026-05-22 - not real-time
$179.04
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Salesforce (CRM) is trading at $179.04, just above its 20‑day SMA of 178.75 and below the 50‑day SMA of 181.93, indicating a tentative technical bounce. The RSI sits at 49.9, suggesting neutral momentum, while the MACD histogram is positive (0.45) and the signal line points to a bullish bias despite a broader bearish trend. Volatility is elevated at 46% 30‑day and beta is modest (0.63), underscoring price swings but limited market‑wide risk. The stock’s DCF fair value of $422 implies an upside of roughly 48%, far above the current price and the median analyst target of $250. Fundamentals remain solid: revenue growth of 12.1%, gross margin near 78%, and free cash flow exceeding $16 billion, while the 1% dividend is backed by a low 21% payout ratio, making it sustainable. Recent material news – an expanded partnership with Google Cloud, a renewed focus on agentic AI, and multiple analyst upgrades with price targets up to $280 – reinforce the growth narrative and provide a catalyst for the projected upside.
Given the combination of a strong cash position, a strategic AI push, and a valuation gap, CRM appears positioned for a rebound toward its fair value. The technical indicators suggest a short‑term support level around $164.33, providing downside protection, while the bullish MACD and stable volume support a near‑term buying opportunity. Over the medium to long term, the undervaluation, high‑growth AI initiatives, and consistent dividend make CRM a compelling buy for investors seeking both growth and income.
Given the combination of a strong cash position, a strategic AI push, and a valuation gap, CRM appears positioned for a rebound toward its fair value. The technical indicators suggest a short‑term support level around $164.33, providing downside protection, while the bullish MACD and stable volume support a near‑term buying opportunity. Over the medium to long term, the undervaluation, high‑growth AI initiatives, and consistent dividend make CRM a compelling buy for investors seeking both growth and income.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support at $164.33 with bullish MACD histogram
- Neutral RSI and stable volume suggest limited downside
- Recent Google Cloud partnership adds immediate catalyst
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~48% and median analyst target of $250
- Strong revenue growth and high free cash flow
- AI and agentic platform expansion driving earnings visibility
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend with low payout ratio
- Strategic positioning in enterprise AI and cloud integration
- Undervaluation relative to fair value and industry peers
Key Metrics & Analysis
Financial Health
Revenue Growth12.10%
Profit Margin17.96%
P/E Ratio23.0
ROE12.40%
ROA5.18%
Debt/Equity29.95
P/B Ratio2.8
Op. Cash Flow$15.0B
Free Cash Flow$16.4B
Industry P/E39.7
Technical Analysis
TrendBearish
RSI49.9
Support$164.33
Resistance$190.31
MA 20$178.75
MA 50$181.93
MA 200$222.37
MACDBullish
VolumeStable
Fear & Greed Index91.73
Valuation
Fair Value$422.36
Target Price$265.01
Upside/Downside48.02%
GradeUndervalued
TypeGrowth
Dividend Yield1.00%
Risk Assessment
Beta0.63
Volatility46.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.